)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Guardant Health
Guardant Health (GH) investor relations material
Guardant Health TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary4 Mar, 2026
Business performance and growth outlook
2025 saw exceptional growth, with accelerating momentum expected to continue into 2026, driven by multiple products gaining market traction.
Guardant360 experienced 25% volume growth in 2025, with 30% in the second half; 2026 guidance is for 20% growth, supported by deeper market penetration and new applications.
Reveal volumes grew over 80% in late 2025, with strong expectations for 2026, especially as new applications and reimbursement catalysts emerge.
SHIELD is projected to more than double its 2025 volume in 2026, supported by expanded sales force and the Quest partnership.
All business segments are described as “firing on all cylinders,” with continued innovation and market adoption anticipated.
Product innovation and portfolio strategy
Transition to a smart liquid biopsy platform with broad epigenetic profiling is driving innovation and adoption.
Multiple new applications are planned for launch, with over a dozen in the pipeline, enhancing clinical utility and physician engagement.
Reveal Ultra will launch in 2026, expanding into tumor-informed MRD testing.
The portfolio is evolving from individual tests to an integrated platform, improving patient management and customer retention.
The app ecosystem allows tailored solutions for different cancer types, supporting diverse clinical needs.
Regulatory and reimbursement developments
FDA approval for the flagship liquid biopsy test is expected in the second half of 2026, consolidating the portfolio and simplifying ordering.
FDA approval will also enable a new ADLT rate in 2027, potentially boosting both liquid and tissue test volumes and financial performance.
Medicare coverage for Reveal breast and reimbursement for therapy response monitoring are anticipated as major volume catalysts.
ACS guideline endorsement for SHIELD is expected soon, which could drive significant volume and commercial reimbursement, especially in states mandating ACS compliance.
Quantify G360 FDA approval's TissueNext volume boost
Shield Quest partnership: volume impact specifics
Reveal Ultra: Differentiated performance and integration
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Guardant Health earnings date
Leerink Global Healthcare Conference 202610 Mar, 2026
Guardant Health
Next Guardant Health earnings date
Leerink Global Healthcare Conference 202610 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Guardant Health, Inc. is a cancer-specific diagnostic company that provides blood tests, data sets, and analytics. The company's blood test detects cancer mutations in blood so that clinicians can prescribe medicines to match specific types of cancer. The company also provides its patient data sets and analytic tools to change the way hospitals model cancer outcomes. The company is based in Redwood City, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage